{"id":1180,"date":"2026-11-19T12:04:09","date_gmt":"2026-11-19T12:04:09","guid":{"rendered":"https:\/\/genes2me.com\/blog\/?p=1180"},"modified":"2026-11-19T12:04:10","modified_gmt":"2026-11-19T12:04:10","slug":"newborn-screening-genetic-testing-india","status":"publish","type":"post","link":"https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/","title":{"rendered":"A Healthy Start Begins with a Few Drops"},"content":{"rendered":"\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" src=\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/11\/image-2.jpeg\" alt=\"\" class=\"wp-image-1181\" width=\"840\" height=\"280\" srcset=\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/11\/image-2.jpeg 602w, https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/11\/image-2-300x100.jpeg 300w\" sizes=\"(max-width: 840px) 100vw, 840px\" \/><\/figure>\n\n\n\n<p>Most newborns look healthy at birth. A small number, though, carry a metabolic or genetic disorder that shows no symptoms in the first weeks while it quietly harms the brain, liver, or other organs.\u00a0<\/p>\n\n\n\n<p>Many of these disorders can be treated if they are found early, and newborn screening is how they are found. All it takes is a few drops of blood from the baby\u2019s heel, collected in the first days of life.&nbsp;<\/p>\n\n\n\n<p>In this post, we explain what newborn screening involves, why it matters in India, and how the G2M Newborn Screening NGS Kit helps laboratories add genetic screening to their services.&nbsp;<\/p>\n\n\n\n<p><strong>What Is Newborn Screening?<\/strong>&nbsp;<\/p>\n\n\n\n<p><a href=\"https:\/\/www.genes2me.com\/ngs\/prenatal-testing\/nbs-panel\">Newborn screening (NBS)<\/a> checks babies for serious hormonal, metabolic, and genetic disorders, ideally 24 to 72 hours after birth. A nurse pricks the baby\u2019s heel and blots a few drops of blood onto a filter-paper card, called a dried blood spot (DBS), which goes to a laboratory for testing.\u00a0<\/p>\n\n\n\n<p>A typical screening panel looks for:&nbsp;<\/p>\n\n\n\n<ol type=\"1\"><li><strong>Congenital hypothyroidism<\/strong>, which can cause intellectual disability if untreated&nbsp;<\/li><li><strong>G6PD deficiency<\/strong>, which can lead to severe anaemia and jaundice&nbsp;<\/li><li><strong>Phenylketonuria (PKU)<\/strong> and other inborn errors of metabolism&nbsp;<\/li><li><strong>Congenital adrenal hyperplasia<\/strong>, which can be life-threatening within weeks&nbsp;<\/li><li><strong>Galactosemia<\/strong> and <strong>biotinidase deficiency<\/strong>&nbsp;<\/li><li><strong>Haemoglobin disorders<\/strong> such as thalassaemia and sickle cell disease&nbsp;<\/li><\/ol>\n\n\n\n<p><em>A positive screen is not a diagnosis. It tells doctors which babies need confirmatory tests.<\/em>&nbsp;<\/p>\n\n\n\n<p><strong>Why It Matters in India<\/strong>&nbsp;<\/p>\n\n\n\n<p>Around 25 million babies are born in India every year, more than in any other country. High genetic diversity, along with consanguineous marriage in some communities, raises the risk of inherited disorders.&nbsp;<\/p>\n\n\n\n<p>Screening has not kept pace. Expanded newborn screening is still patchy; many parents have never heard of it, and many babies are tested for only one or two conditions, or none at all.&nbsp;<\/p>\n\n\n\n<p>That gap matters because treatment is often simple: a daily thyroid tablet, a special diet, or avoiding certain medicines. Caught early, many of these disorders become manageable conditions instead of lifelong disabilities.&nbsp;<\/p>\n\n\n\n<p><strong>Going Beyond Biochemistry<\/strong>&nbsp;<\/p>\n\n\n\n<p>Standard screening measures biochemical markers in the blood. It works well, but it covers a limited list of disorders, some markers shift with feeding or prematurity, and false positives lead to worry and repeat tests.&nbsp;<\/p>\n\n\n\n<p>Genomic newborn screening uses <a href=\"https:\/\/www.genes2me.com\/next-generation-sequencing-clinical-panels\">next-generation sequencing (NGS)<\/a> to read the baby\u2019s DNA from the same dried blood spot. A single sequencing run examines hundreds of genes at once.&nbsp;<\/p>\n\n\n\n<p>Used alongside biochemical screening, it helps doctors:&nbsp;<\/p>\n\n\n\n<ol type=\"1\" start=\"7\"><li>Detect disorders that have no reliable biochemical marker&nbsp;<\/li><li>Confirm or rule out abnormal biochemical results sooner&nbsp;<\/li><li>Pinpoint the genetic cause, which guides treatment and family counselling&nbsp;<\/li><\/ol>\n\n\n\n<p><strong>The G2M Newborn Screening NGS Kit<\/strong>&nbsp;<\/p>\n\n\n\n<p>The G2M <a href=\"https:\/\/genes2me.com\/blog\/tag\/nbs-testing-kit\/\">Newborn Screening NGS Kit<\/a> is developed and manufactured in India. It screens 335 genes linked to 340 diseases from a single sample, far beyond the scope of standard newborn testing.\u00a0<\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" src=\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/11\/image-3.jpeg\" alt=\"\" class=\"wp-image-1182\" width=\"841\" height=\"841\" srcset=\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/11\/image-3.jpeg 602w, https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/11\/image-3-300x300.jpeg 300w, https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/11\/image-3-150x150.jpeg 150w\" sizes=\"(max-width: 841px) 100vw, 841px\" \/><\/figure>\n\n\n\n<p><strong>Key features<\/strong>&nbsp;<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td><strong>Feature<\/strong>&nbsp;<\/td><td><strong>Details<\/strong>&nbsp;<\/td><\/tr><tr><td><strong>Coverage<\/strong>&nbsp;<\/td><td>Whole exonic regions of 335 genes linked to 340 diseases (~1.5 Mb target)&nbsp;<\/td><\/tr><tr><td><strong>Chemistry<\/strong>&nbsp;<\/td><td>Hybridization capture-based target enrichment for high specificity and uniform coverage&nbsp;<\/td><\/tr><tr><td><strong>Sample<\/strong>&nbsp;<\/td><td>Dried blood spot from a heel prick (5 punches of 3.2 mm) or 1 ml of peripheral blood&nbsp;<\/td><\/tr><tr><td><strong>Sequencers<\/strong>&nbsp;<\/td><td>Compatible with Illumina, MGI, Element Biosciences (AVITI) and Thermo Fisher platforms&nbsp;<\/td><\/tr><tr><td><strong>Library preparation<\/strong>&nbsp;<\/td><td>Manual, or automated on G2M&#8217;s EZY AutoPrep-48 workstation&nbsp;<\/td><\/tr><tr><td><strong>Reporting<\/strong>&nbsp;<\/td><td>CliSeq Interpreter software, cloud-based or on a local server, produces ACMG-based reports of clinically significant mutations&nbsp;<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Panel performance<\/strong>&nbsp;<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td><strong>Coverage uniformity<\/strong>&nbsp;<\/td><td><strong>Sensitivity<\/strong>&nbsp;<\/td><td><strong>Reproducibility<\/strong>&nbsp;<\/td><td><strong>On-target ratio<\/strong>&nbsp;<\/td><\/tr><tr><td><strong>97%<\/strong>&nbsp;<\/td><td><strong>97%<\/strong>&nbsp;<\/td><td><strong>96.1%<\/strong>&nbsp;<\/td><td><strong>&gt;78%<\/strong>&nbsp;<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Disorders covered<\/strong>&nbsp;<\/p>\n\n\n\n<ol type=\"1\" start=\"10\"><li><strong>Metabolic disorders: <\/strong>amino acid, organic acid and fatty acid \u03b2-oxidation disorders; carbohydrate and endocrine disorders; metabolic epilepsies; and other inborn errors of metabolism&nbsp;<\/li><li><strong>Genetic disorders: <\/strong>hereditary deafness, \u03b2-thalassaemia, haemophilia B, Noonan syndrome, Marfan syndrome and others&nbsp;<\/li><\/ol>\n\n\n\n<p><strong>What the report shows<\/strong>&nbsp;<\/p>\n\n\n\n<p>Each report lists every clinically significant variant found, with its gene, zygosity, associated disease, inheritance pattern and ACMG classification, followed by an interpretation and recommended next steps.&nbsp;<\/p>\n\n\n\n<p>In one sample report, a 22-day-old baby tested for deafness was found to carry a pathogenic homozygous variant in the GJB2 gene. A clear answer like this lets the family start hearing support early.&nbsp;<\/p>\n\n\n\n<p><strong>Every Baby Deserves to Be Screened<\/strong>&nbsp;<\/p>\n\n\n\n<p>Newborn screening is one of the simplest ways to protect a child\u2019s future. A few drops of blood today can prevent years of illness later.&nbsp;<\/p>\n\n\n\n<p>This Newborn Screening Awareness season, we encourage parents to ask their doctor about screening before leaving the hospital, and laboratories and hospitals to make genomic screening available to the families they serve.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Most newborns look healthy at birth. A small number, though, carry a metabolic or genetic disorder that shows no symptoms in the first weeks while&hellip;<\/p>\n","protected":false},"author":1,"featured_media":1184,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1,8],"tags":[533,532,31,534],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Newborn Screening in India: Benefits of Genetic Testing<\/title>\n<meta name=\"description\" content=\"Learn how newborn screening detects genetic and metabolic disorders early and how the G2M Newborn Screening NGS Kit screens 335 genes linked to 340 diseases.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Newborn Screening in India: Benefits of Genetic Testing\" \/>\n<meta property=\"og:description\" content=\"Learn how newborn screening detects genetic and metabolic disorders early and how the G2M Newborn Screening NGS Kit screens 335 genes linked to 340 diseases.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/\" \/>\n<meta property=\"og:site_name\" content=\"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-19T12:04:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-19T12:04:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/11\/G2M_NBS_Thumbnail_HQ-1_page-0001.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1875\" \/>\n\t<meta property=\"og:image:height\" content=\"986\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Genes2Me\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Genes2Me\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/genes2me.com\/blog\/#organization\",\"name\":\"Genes2Me\",\"url\":\"https:\/\/genes2me.com\/blog\/\",\"sameAs\":[],\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/genes2me.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2023\/09\/cropped-G2M150x150.jpg\",\"contentUrl\":\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2023\/09\/cropped-G2M150x150.jpg\",\"width\":150,\"height\":69,\"caption\":\"Genes2Me\"},\"image\":{\"@id\":\"https:\/\/genes2me.com\/blog\/#\/schema\/logo\/image\/\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/genes2me.com\/blog\/#website\",\"url\":\"https:\/\/genes2me.com\/blog\/\",\"name\":\"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems\",\"description\":\"Real Time PCR Molecular Diagnostics NGS Cancer Screening Sequencing COVID-19 Rapid Antigen Antibody Made in India Manufacturer Clinical\/Whole Exome\",\"publisher\":{\"@id\":\"https:\/\/genes2me.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/genes2me.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/\",\"url\":\"https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/\",\"name\":\"Newborn Screening in India: Benefits of Genetic Testing\",\"isPartOf\":{\"@id\":\"https:\/\/genes2me.com\/blog\/#website\"},\"datePublished\":\"2026-11-19T12:04:09+00:00\",\"dateModified\":\"2026-11-19T12:04:10+00:00\",\"description\":\"Learn how newborn screening detects genetic and metabolic disorders early and how the G2M Newborn Screening NGS Kit screens 335 genes linked to 340 diseases.\",\"breadcrumb\":{\"@id\":\"https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/genes2me.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A Healthy Start Begins with a Few Drops\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/\"},\"author\":{\"name\":\"Genes2Me\",\"@id\":\"https:\/\/genes2me.com\/blog\/#\/schema\/person\/10206ca125f3a19893d76130599c48aa\"},\"headline\":\"A Healthy Start Begins with a Few Drops\",\"datePublished\":\"2026-11-19T12:04:09+00:00\",\"dateModified\":\"2026-11-19T12:04:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/\"},\"wordCount\":789,\"publisher\":{\"@id\":\"https:\/\/genes2me.com\/blog\/#organization\"},\"keywords\":[\"Genetic Testing for Newborns\",\"Newborn Genetic Screening\",\"newborn screening\",\"Newborn Screening in India\"],\"articleSection\":[\"Dignostic Solution\",\"Newborn Screening\"],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/genes2me.com\/blog\/#\/schema\/person\/10206ca125f3a19893d76130599c48aa\",\"name\":\"Genes2Me\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/genes2me.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d657e6ab646ef1896bc855e2b96e924e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d657e6ab646ef1896bc855e2b96e924e?s=96&d=mm&r=g\",\"caption\":\"Genes2Me\"},\"description\":\"Established in 2016, Genes2Me is a leading molecular diagnostics company committed to transforming healthcare through innovative, high-quality in vitro diagnostic (IVD) solutions. Built on a strong foundation of scientific excellence and precision engineering, Genes2Me develops and manufactures advanced diagnostic technologies that enable accurate, reliable, and timely clinical decision-making across diverse healthcare settings worldwide. With a comprehensive and rapidly expanding portfolio, Genes2Me offers cutting-edge solutions across molecular diagnostics, including Next Generation Sequencing (NGS) clinical assays, point-of-care (POC) testing platforms, RT-PCR kits and instruments, as well as nucleic acid extraction kits and automation systems. Designed to meet the evolving needs of modern laboratories and clinicians, our products combine performance, scalability, and operational efficiency. A vast majority of Genes2Me products are CE-IVD marked, reflecting our commitment to global quality benchmarks, regulatory compliance, and uncompromising product standards. At the heart of our innovation are proprietary platforms such as OnePCR and Rapi-Q, developed to deliver rapid, multiplex, and highly sensitive molecular detection with streamlined workflows and minimal turnaround time. OnePCR integrates automated nucleic acid extraction and RT-PCR into a single, seamless workflow, enabling the detection of up to 20 targets from a single sample with exceptional precision and efficiency. The Rapi-Q series is engineered for fast, sensitive, and multiplex testing with a larger throughput, empowering healthcare providers with timely diagnostic insights that support improved patient outcomes. In genomics, Genes2Me offers one of the industry\u2019s most comprehensive NGS clinical assay portfolios, spanning oncology, liquid biopsy, whole exome sequencing, NIPT and pharmacogenomics. Complementing this portfolio is EZY AutoPrep, our advanced automated library preparation workstation designed to optimize NGS library preparation through enhanced accuracy, reproducibility, and scalability. Our genomics ecosystem is further strengthened by CliSeq Interpreter, a cloud-based bioinformatics platform that enables accurate, flexible, and intuitive interpretation of complex genomic data, helping laboratories generate high-confidence insights with efficiency and ease. Driven by innovation, quality, and a global vision, Genes2Me continues to redefine the future of molecular diagnostics\u2014delivering integrated solutions that advance precision medicine and improve lives worldwide.\",\"sameAs\":[\"https:\/\/www.genes2me.com\/\"],\"url\":\"https:\/\/genes2me.com\/blog\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Newborn Screening in India: Benefits of Genetic Testing","description":"Learn how newborn screening detects genetic and metabolic disorders early and how the G2M Newborn Screening NGS Kit screens 335 genes linked to 340 diseases.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/","og_locale":"en_US","og_type":"article","og_title":"Newborn Screening in India: Benefits of Genetic Testing","og_description":"Learn how newborn screening detects genetic and metabolic disorders early and how the G2M Newborn Screening NGS Kit screens 335 genes linked to 340 diseases.","og_url":"https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/","og_site_name":"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems","article_published_time":"2026-11-19T12:04:09+00:00","article_modified_time":"2026-11-19T12:04:10+00:00","og_image":[{"width":1875,"height":986,"url":"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/11\/G2M_NBS_Thumbnail_HQ-1_page-0001.jpg","type":"image\/jpeg"}],"author":"Genes2Me","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Genes2Me","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/genes2me.com\/blog\/#organization","name":"Genes2Me","url":"https:\/\/genes2me.com\/blog\/","sameAs":[],"logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/genes2me.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2023\/09\/cropped-G2M150x150.jpg","contentUrl":"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2023\/09\/cropped-G2M150x150.jpg","width":150,"height":69,"caption":"Genes2Me"},"image":{"@id":"https:\/\/genes2me.com\/blog\/#\/schema\/logo\/image\/"}},{"@type":"WebSite","@id":"https:\/\/genes2me.com\/blog\/#website","url":"https:\/\/genes2me.com\/blog\/","name":"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems","description":"Real Time PCR Molecular Diagnostics NGS Cancer Screening Sequencing COVID-19 Rapid Antigen Antibody Made in India Manufacturer Clinical\/Whole Exome","publisher":{"@id":"https:\/\/genes2me.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genes2me.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/","url":"https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/","name":"Newborn Screening in India: Benefits of Genetic Testing","isPartOf":{"@id":"https:\/\/genes2me.com\/blog\/#website"},"datePublished":"2026-11-19T12:04:09+00:00","dateModified":"2026-11-19T12:04:10+00:00","description":"Learn how newborn screening detects genetic and metabolic disorders early and how the G2M Newborn Screening NGS Kit screens 335 genes linked to 340 diseases.","breadcrumb":{"@id":"https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genes2me.com\/blog\/"},{"@type":"ListItem","position":2,"name":"A Healthy Start Begins with a Few Drops"}]},{"@type":"Article","@id":"https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/#article","isPartOf":{"@id":"https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/"},"author":{"name":"Genes2Me","@id":"https:\/\/genes2me.com\/blog\/#\/schema\/person\/10206ca125f3a19893d76130599c48aa"},"headline":"A Healthy Start Begins with a Few Drops","datePublished":"2026-11-19T12:04:09+00:00","dateModified":"2026-11-19T12:04:10+00:00","mainEntityOfPage":{"@id":"https:\/\/genes2me.com\/blog\/newborn-screening-genetic-testing-india\/"},"wordCount":789,"publisher":{"@id":"https:\/\/genes2me.com\/blog\/#organization"},"keywords":["Genetic Testing for Newborns","Newborn Genetic Screening","newborn screening","Newborn Screening in India"],"articleSection":["Dignostic Solution","Newborn Screening"],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/genes2me.com\/blog\/#\/schema\/person\/10206ca125f3a19893d76130599c48aa","name":"Genes2Me","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/genes2me.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d657e6ab646ef1896bc855e2b96e924e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d657e6ab646ef1896bc855e2b96e924e?s=96&d=mm&r=g","caption":"Genes2Me"},"description":"Established in 2016, Genes2Me is a leading molecular diagnostics company committed to transforming healthcare through innovative, high-quality in vitro diagnostic (IVD) solutions. Built on a strong foundation of scientific excellence and precision engineering, Genes2Me develops and manufactures advanced diagnostic technologies that enable accurate, reliable, and timely clinical decision-making across diverse healthcare settings worldwide. With a comprehensive and rapidly expanding portfolio, Genes2Me offers cutting-edge solutions across molecular diagnostics, including Next Generation Sequencing (NGS) clinical assays, point-of-care (POC) testing platforms, RT-PCR kits and instruments, as well as nucleic acid extraction kits and automation systems. Designed to meet the evolving needs of modern laboratories and clinicians, our products combine performance, scalability, and operational efficiency. A vast majority of Genes2Me products are CE-IVD marked, reflecting our commitment to global quality benchmarks, regulatory compliance, and uncompromising product standards. At the heart of our innovation are proprietary platforms such as OnePCR and Rapi-Q, developed to deliver rapid, multiplex, and highly sensitive molecular detection with streamlined workflows and minimal turnaround time. OnePCR integrates automated nucleic acid extraction and RT-PCR into a single, seamless workflow, enabling the detection of up to 20 targets from a single sample with exceptional precision and efficiency. The Rapi-Q series is engineered for fast, sensitive, and multiplex testing with a larger throughput, empowering healthcare providers with timely diagnostic insights that support improved patient outcomes. In genomics, Genes2Me offers one of the industry\u2019s most comprehensive NGS clinical assay portfolios, spanning oncology, liquid biopsy, whole exome sequencing, NIPT and pharmacogenomics. Complementing this portfolio is EZY AutoPrep, our advanced automated library preparation workstation designed to optimize NGS library preparation through enhanced accuracy, reproducibility, and scalability. Our genomics ecosystem is further strengthened by CliSeq Interpreter, a cloud-based bioinformatics platform that enables accurate, flexible, and intuitive interpretation of complex genomic data, helping laboratories generate high-confidence insights with efficiency and ease. Driven by innovation, quality, and a global vision, Genes2Me continues to redefine the future of molecular diagnostics\u2014delivering integrated solutions that advance precision medicine and improve lives worldwide.","sameAs":["https:\/\/www.genes2me.com\/"],"url":"https:\/\/genes2me.com\/blog\/author\/admin\/"}]}},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/posts\/1180"}],"collection":[{"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/comments?post=1180"}],"version-history":[{"count":2,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/posts\/1180\/revisions"}],"predecessor-version":[{"id":1185,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/posts\/1180\/revisions\/1185"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/media\/1184"}],"wp:attachment":[{"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/media?parent=1180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/categories?post=1180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/tags?post=1180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}